Streptamer isolated donor lymphocytes classified by the EMEA as non ATMP's
STAGE Cell Therapeutics GmbH announced that EMEA has classified CMV-specific as non ATMP's (Advanced Therapy Medicinal Product). The classification as non ATMP substantially reduces the cost and time to market for Streptamer-isolated cell therapeutics.
The Streptamer' technology enables the complete dissociation of reagents used for antigen-specific staining or isolation of T-cells leaving the isolated T-cells phenotypically and functionally undistinguishable from naturally occurring cells.
“We believe that the decision of the EMEA will strongly support our Streptamer technology as a unique platform for high quality and economic generation of cell therapeutics” said Dr. Lothar Germeroth, COO of STAGE.
Streptamer-isolated cells are currently investigated in several clinical studies for treatment of viral infections. Together with academic partners STAGE is planning to extend the Streptamer-based cell therapies to different cancer indications such as leukemia and melanoma.
“We are actively seeking clinical cooperations with researchers who are interested to rapidly advance their preclinical cell therapy projects into the clinics” stated Dr. Herbert Stadler, CEO of STAGE.
With the close academic cooperations STAGE will be able to demonstrate a variety of successful applications of the Streptamer technology in cell therapy providing attractive new treatment options for currently uncurable diseases.
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
